Diagnostic evaluation of endoscopic ultrasonography with submucosal saline injection for differentiating between T1a and T1b early gastric cancer

BACKGROUND Endoscopic ultrasonography (EUS) has become a reliable method for predicting the invasion depth of early gastric cancer (EGC). However, diagnostic accuracy of EUS is affected by several factors. In particular, it is difficult to differentiate between T1a and T1b EGC through EUS. AIM To confirm whether submucosal saline injection (SSI) could improve the accuracy of EUS in distinguishing T1a and T1b lesions in EGC. METHODS Twenty-four patients with EGC were examined by EUS and subsequently by SSI combined EUS to compare the degree of tumor invasion. Then, they underwent endoscopic or surgical resection within 7 d. The diagnostic accuracy of EUS and SSI combined EUS was evaluated based on the final pathological findings postoperatively. Saline injected into the submucosa acted as an echoic contrast enhancing agent and had the effect of distinguishing the mucosal and submucosal layers clearly. RESULTS Of total 24 patients, 23 were diagnosed with EGC (T1 cancer: 13 as T1a, and 10 as T1b). Standard EUS identified 6 of 13 T1a cancer patients and 3 of 10 T1b cancer patients. Whereas, EUS-SSI identified 12 of 13 T1a cancer patients and 6 of 10 T1b cancer patients. In this study, SSI combined EUS was more accurate than EUS alone in diagnosing T1a and T1b lesions of EGC (75.0% and 37.5%, respectively). CONCLUSION SSI improved the diagnostic accuracy of EUS in distinguishing between the T1a and T1b stages in EGC.

Automated summary

This study confirms that submucosal saline injection (SSI) can improve the accuracy of endoscopic ultrasonography (EUS) in distinguishing T1a and T1b lesions in early gastric cancer (EGC).